TGS1 and cancer: Ultimately, the goal in the field is to define critical intervention points, such as the inhibition of PAPD5 and potentially TGS1 [20,23,61,62], that can be targeted to ameliorate deficiencies in telomere maintenance or to inhibit telomerase activity in cancer cells.